These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 4160950)

  • 21. Comparison between various methods used to control dicumarol therapy.
    Korsan-Bengtsen K
    Acta Med Scand; 1970 Oct; 188(4):327-35. PubMed ID: 4097988
    [No Abstract]   [Full Text] [Related]  

  • 22. A contribution to the aetiopathogenesis and treatment of acute thrombophlebitis.
    Denev B
    J Cardiovasc Surg (Torino); 1969; 10(5):362-5. PubMed ID: 4189004
    [No Abstract]   [Full Text] [Related]  

  • 23. The relationship between prothrombin time and bleeding in the clinical use of dicumarol after operation.
    HOGBEN CA; ALLEN EV
    Circulation; 1950 Sep; 2(3):369-72. PubMed ID: 15434938
    [No Abstract]   [Full Text] [Related]  

  • 24. Secondary prophylaxis of venous thromboembolism: rational use of oral anticoagulants.
    Piovella F; Siragusa S; Barone M; Beltrametti C; Carbone S; Vicentini L; Ascari E
    Haematologica; 1995; 80(2 Suppl):87-91. PubMed ID: 7543072
    [No Abstract]   [Full Text] [Related]  

  • 25. Coumarin resistance in a Negro woman.
    Zager J; Tjandramaga TB; Cucinell SA; Dayton PG
    Ann Intern Med; 1973 May; 78(5):775-6. PubMed ID: 4123117
    [No Abstract]   [Full Text] [Related]  

  • 26. Prothrombin Time in Dicoumarol Therapy.
    James GA
    J Clin Pathol; 1949 Feb; 2(1):45-8. PubMed ID: 16810827
    [No Abstract]   [Full Text] [Related]  

  • 27. [A study on anticoagulation for cardiovascular diseases using international normalized ratio (INR)].
    Izumi Y; Asada H; Hoshino Z; Yoshida H; Kubota H
    Kyobu Geka; 1996 Nov; 49(12):997-1000. PubMed ID: 8937001
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Standardized estimation of prothrombin activity and the accurate control of dicumarol therapy.
    ASTRUP T; MULLERTZ S
    Schweiz Med Wochenschr; 1954 Jul; 84(29):815-7. PubMed ID: 13195632
    [No Abstract]   [Full Text] [Related]  

  • 29. Rapid fibrinogen determination with the prothrombin time using a potentiophotometer.
    Carroll WE; Jackson RD
    Res Commun Mol Pathol Pharmacol; 1995 Jul; 89(1):67-76. PubMed ID: 7582863
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Delayed medical treatment of cerebral ischemic accidents. Therapeutic combination of anticoagulants and platelet antiaggregation agents].
    Diez Tejedor E; Barreiro Tella P; Acosta Varo J; Arpa Gutiérrez J
    Arch Neurobiol (Madr); 1980; 43(1):29-44. PubMed ID: 6155890
    [No Abstract]   [Full Text] [Related]  

  • 31. [Laboratory control over warfarin therapy in patients with acute coronary syndrome].
    Baluda MV; Lopukhina MV; Fomina VM; Lopukhin VO
    Ter Arkh; 2005; 77(10):68-71. PubMed ID: 16320690
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of bishydroxycoumarin activity by phenobarbital.
    Corn M; Rockett JF
    Med Ann Dist Columbia; 1965 Dec; 34(12):578-9 passim. PubMed ID: 4158838
    [No Abstract]   [Full Text] [Related]  

  • 33. [Determination of the prothrombin time during dicumarol treatment].
    STRENGERS T; LINDEBOOM HH
    Ned Tijdschr Geneeskd; 1948 Sep; 92(39):2991-7. PubMed ID: 18894333
    [No Abstract]   [Full Text] [Related]  

  • 34. Current trends in the treatment of coronary disease; discussion of dicumarol therapy.
    FALK OP
    South Med J; 1947 Jun; 40(6):501-8. PubMed ID: 20241491
    [No Abstract]   [Full Text] [Related]  

  • 35. [Our technic for determination of prothrombin time].
    SAMAMA M
    Sang; 1956; 27(6):603-6. PubMed ID: 13390782
    [No Abstract]   [Full Text] [Related]  

  • 36. [Evaluation of rapid method of determination of the prothrombin time].
    Korolko A; Hruczkowska E; Bielak J
    Pol Tyg Lek; 1966 Apr; 21(17):632-3. PubMed ID: 4160950
    [No Abstract]   [Full Text] [Related]  

  • 37. [Preliminary evaluation of clinical treatment with anticoaagulants in our observations].
    Gajewski J; Rebandel M; Rymaszewski Z
    Pol Tyg Lek; 1968 Jan; 23(4):139-42. PubMed ID: 4172240
    [No Abstract]   [Full Text] [Related]  

  • 38. [Correlation of thromboplastin times in dicumarol treated patients using various preparations of thrombokinase].
    Averdunk R; Borner K
    Z Klin Chem Klin Biochem; 1970 May; 8(3):263-8. PubMed ID: 4097158
    [No Abstract]   [Full Text] [Related]  

  • 39. Evaluation of anticoagulant therapy in focal ischemic cerebrovascular disease: further observations.
    Siekert RG
    Res Publ Assoc Res Nerv Ment Dis; 1966; 41():359-66. PubMed ID: 4163329
    [No Abstract]   [Full Text] [Related]  

  • 40. [Coronary thrombosis and blood coagulability with reference to the suspension of anticoagulant therapy].
    Vanacore C; Recalcati P; Sessa A
    Haematol Lat; 1968; 11(4):387-417. PubMed ID: 4186820
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.